203 filings
8-K
EVFM
Evofem Biosciences, Inc.
15 May 24
Evofem Biosciences Announces Financial Results for the First Quarter of 2024
6:50am
8-K
EVFM
Evofem Biosciences, Inc.
2 May 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EVFM
Evofem Biosciences, Inc.
28 Mar 24
Regulation FD Disclosure
5:11pm
8-K
EVFM
Evofem Biosciences, Inc.
27 Mar 24
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
8:36am
8-K
EVFM
Evofem Biosciences, Inc.
6 Mar 24
Entry into a Material Definitive Agreement
5:14pm
8-K
epn8 76a0p1tp9eb
1 Feb 24
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
9:05am
8-K
g18c6m781d5nscm 0t
31 Jan 24
Entry into a Material Definitive Agreement
4:26pm
8-K/A
6bpfh5 he
25 Jan 24
Financial Statements and Exhibits
4:23pm
8-K
4uhbv2e6tldp
11 Jan 24
Entry into a Material Definitive Agreement
4:53pm
8-K
65t4 9gl4uy0na
26 Dec 23
Entry into a Material Definitive Agreement
5:37pm
8-K
yxw7un 11hcypgd
12 Dec 23
Entry into a Material Definitive Agreement
5:17pm
8-K
zrilzz 75
7 Dec 23
Entry into a Material Definitive Agreement
4:05pm
8-K
gaxwy80
14 Nov 23
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
12:00am
8-K
yzbqzn5h np03m5c1
24 Oct 23
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
7:40am
8-K
t9opm7ma9
3 Oct 23
Entry into a Material Definitive Agreement
4:07pm
8-K
lzgg22bp 49bluvm3nsj
27 Sep 23
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi Until Evofem’s Phexxi Patents Expire
8:50am
8-K
8tyd0psf qwb53ind1
15 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
6rvg9vosyoggk
11 Sep 23
Entry into a Material Definitive Agreement
8:01am
8-K
ruiz5
28 Aug 23
Regulation FD Disclosure
4:30pm
8-K/A
gem tyff2r
18 Aug 23
Entry into a Material Definitive Agreement
4:05pm